Horizon Therapeutics Public Ltd Co — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022)

$3.6B

Net Income/Loss (FY2022)

$521.5M

Total Assets (FY2022)

$9.1B

Total Equity (FY2022)

$5.1B

Cash Flows from Operating Activities (FY2022)

$1.3B

Source: Horizon Therapeutics Public Ltd Co 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.